3Viscoli C, Girmenia C, Marinus A, et al. Candidaemia in cancer patients: a prospective, multicenter surveillance study by the Invasire Fungal Infection Group(IFIG) of the European Organization for Reseamh and Treatment of Cancer (EORTC). Clin Infect Dis, 1999; 28:1071 -1079
4Leung AY, China CS, Ho PL, et al. Candida tropiealis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect, 2002; 50:316-319
5Poplace DG, Jacobs SA. Candida arthritis treated with amphotericin B. J Pediatra, 1975; 87(Pt I) :989 -990
6Bayer AS, Guze LB. Fungal arthritis. I. Candida arthritis: diagnostic and prognostic implications and therapeutic considerations. Semin Arthritis Rheum, 1978 ; 8 : 142 - 150
7Fainstein V, Gilmore C, Hopfer RL, et al. Septic arthritis due to Candida species in patients with cancer: report of five cases and review of the literature. Rev Infect Dis, 1982 ; 4:78 - 85
8Mandel DR, Segal AM, Wysenbeek A j, et al. Two unusual strains of Candida arthritis. Am J Med Sci, 1984; 258:25 -27
9Nguyen VQ, Penn RL. Candida krusei infectious arthritis. A rare complication of neutmpenia. Am J Med, 1987 ; 83:963 - 965
10O'Meeghan T, Varcoe R, Thoma M, et al. Flueonazole concentration in joint fluid during successful treatment of Candida albieans septic arthritis. J Antimicrob Chemother, 1990; 26:601 -602
